Formulation and Delivery
.png)
Anthony James
Executive Director, Business Development
Altasciences
Cypress, California
Lisa Sanford
Vice President Business Development
Altasciences
Overland Park, Kansas
Description: In early-stage clinical development, speed and adaptability are critical to avoiding costly delays and advancing toward market approval. A “Pharmacy On-Demand” approach enables real-time formulation adjustments during first-in-human studies—so emerging clinical data, not assumptions, determines the optimal dose and excipient mix before scaling up to full GMP manufacturing.
The process begins with early formulation work and seamlessly transitions to producing small GMP batches under streamlined “GMP-light” conditions, ready for immediate clinical use. This methodology conserves valuable API, accelerates decision-making, and ensures the formulation moving forward is supported by solid evidence.
By maintaining momentum from proof-of-concept through to commercial readiness, this strategy helps drug developers bring therapies to patients faster and with greater confidence.